Clinical-Browse

Result: 81 - 96 of 96

DownLoad :

fasta

FASTA

html

HTML

xls

XLS

xml

XML

	DRAMP ID	NAME	Description	Medical_use	Stage of development	Company
	DRAMP29318	PXL01	Synthetic macrocyclic 25-amino acid peptide derived from human lactoferricin	Prevention of post-surgical adhesion formation in hand surgery	Phase II/III	Promore Pharma (formerly Pergamum AB)
	DRAMP29319	HXP124	Plant defensin	Fungal nail infection (onychomycosis)	Phase II	Hexima
	DRAMP29320	DPK-060	Derived from kininogen, cationic random-coil peptide	Atopic dermatitis, Otitis externa	Phase II	DermaGen AB/Pergamum AB/Karolinska Development AB
	DRAMP29321	Lotilibcin(WAP-8294A2)	Lipodepsipeptide	Methicillin-resistant S. aureus	Phase I/II	aRigen Pharmaceuticals, Green Cross Corporation
	DRAMP29322	NVB302	Synthetic type B lantibiotic	C. difficile infections	Phase I	Novacta Biosystems Ltd.
	DRAMP29323	EA360	Linear tetrapeptide, derived from human chorionic gonadotropin	Systemic inflammatory response and renal function	Phase IIa/b current	Exponential Biotherapies
	DRAMP29324	Friulimicin B	Friulimicin B is a naturally occurring antibiotic produced by a micro-organism, Actinoplanes friuliensis. It shows strong cidal activity against a number of Gram-positive pathogens which commonly cause serious infections in hospital patients and which are becoming more routinely acquired in the community.	Pneumonia, staphylococcal skin infections	Phase I	MerLion/Pharmaceuticals
	DRAMP29325	TD-1792(Cefilavancin)	Cefilavancin is a covalently-linked glycopeptide-cephalosporin (beta-lactam) heterodimer antibiotic that exhibits substantially greater activity than its component parts against Gram-positive bacteria.	Gram-positive infections, Skin and soft tissue infections	Phase III	GlaxoSmithKline Co., Theravance Biopharma Inc., R-Pharm
	DRAMP29326	LTX-315(Oncopore, Ruxotemitide)	Ruxotemitide is a peptide derived from human lactoferrin, with potential lytic and immunostimulating activities.	Solid tumors	Phase I	Lytix Biopharma
	DRAMP29327	ANG1005(Paclitaxel trevatide)	Paclitaxel Trevatide is a peptide-drug conjugate containing the taxane paclitaxel covalently linked to the proprietary 19 amino acid peptide angiopep-2, in a 3:1 ratio, with potential antineoplastic activity.	Breast cancer, brain metastases	Phase II	Angiochem Inc.
	DRAMP29328	Polymyxin B	Polymyxin B is a polymyxin antibiotic used to treat a wide variety of infections in the body.They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes.	Treatment of infections of the urinary tract, meninges, and blood stream, caused by susceptible strains of Pseudomonas aeruginosa	In market	Unknown
	DRAMP29329	Tyrothricin	A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines (60%) and several gramicidins (20%) and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically.Tyrothricin is a topical antibiotic with broad spectrum activity against Gram positive bacteria and some fungal infections.	Treatment of infected skin and infected oropharyngeal mucous membranes	In market	Unknown
	DRAMP29330	Vancomycin	Vancomycin is a glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.	Treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.	In market	Unknown
	DRAMP29331	Onc72	derived from Oncocin	Treatment of antibiotic-susceptible K. pneumoniae	Preclinical	Unknown
	DRAMP29332	Gramicidin S	Cyclic peptide biosynthesized from gramicidin in Bacillus brevis; comprises two identical pentapeptides coupled head to tail.	Potent against gram-negative and gram-positive bacteria and fungi restricted use as spermicide and to treat genital ulcers caused by STD	In market	Unknown
	DRAMP29333	Gramicidin D	Gramcidin D is a heterogeneous mixture of three antibiotic compounds, gramicidins A, B and C, making up 80%, 6%, and 14% respectively all of which are obtained from the soil bacterial species Bacillus brevis and called collectively gramicidin D. Gramcidins are 15 residue peptides with alternating D and L amino acids, which assemble inside of the hydrophobic interior of the cellular lipid bilayer to form a β-helix. Active against most Gram-positive bacteria and some Gram-negative organisms, Gramicidin D is used primarily as a topical antibiotic and is also found in Polysporin ophthalmic solution.	Skin lesions, surface wounds and eye infections	In market	Unknown